Add to Twitter
Takeda Unveils New Dengue Vaccine Manufacturing Plant in Germany
− The manufacturing plant opening marks an important milestone for Takeda’s mission to tackle the global threat of dengue

− The site will be utilized for formulation, fill, finish and secondary packaging of Takeda’s dengue vaccine candidate

− Takeda’s dengue vaccine candidate is currently being evaluated in the pivotal Phase 3 Tetravalent Immunization against Dengue Efficacy Study (TIDES) trial1